Pensionfund Sabic Regeneron Pharmaceuticals, Inc. Transaction History

Pensionfund Sabic

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 06, 2022	SELL	$548.35 - $738.84 $274,175 - $369,420	-500 Reduced 15.15%	2,800 $1.66 Million
Q1 2022 Apr 12, 2022	SELL	$595.12 - $698.43 $535,608 - $628,587	-900 Reduced 21.43%	3,300 $2.31 Million
Q3 2021 Oct 06, 2021	BUY	$574.03 - $680.96 $2.41 Million - $2.86 Million	4,200 New	4,200 $2.54 Million
Q2 2019 Jul 02, 2019	SELL	$299.6 - $414.82 $1.2 Million - $1.66 Million	-4,000 Closed	0 $0
Q1 2019 Apr 01, 2019	SELL	$372.08 - $439.57 $372,080 - $439,570	-1,000 Reduced 20.0%	4,000 $1.64 Million
Q4 2018 Jan 02, 2019	BUY	$335.82 - $403.04 $1.68 Million - $2.02 Million	5,000 New	5,000 $1.87 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Pensionfund Sabic, based on Form 13F filings with the SEC.

Stay updated on Pensionfund Sabic with notifications on news.